Last updated on July 2019

Post Authorisation Safety Study With Raxone in LHON Patients

Brief description of study

This study is a multicentre, prospective, non-interventional post-authorisation safety study (PASS) of the clinical outcomes for patients with LHON treated with Raxone.

No medication will be provided as part of this study. Raxone will be obtained through commercial channels.

Clinical Study Identifier: NCT02771379

Find a site near you

Start Over